Vestal Point Capital »

Galecto shares owned by Vestal Point Capital

Quarter-by-quarter ownership of Galecto (DMRA) shares owned by Vestal Point Capital from 13F filings

Historical chart of Vestal Point Capital investment in Galecto

Tip: Access up to 7 years of quarterly data

All positions including Galecto held by Vestal Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galecto by Vestal Point Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $16M 600k 25.90

More positions owned by Vestal Point Capital

Revolution Medicines (RVMD)
BioMarin Pharmaceutical (BMRN)
Abivax SA Sponsored Ads (ABVX)
Neurocrine Biosciences (NBIX)
Arrowhead Pharmaceuticals (ARWR)
Enliven Therapeutics (ELVN)
Repligen Corporation (RGEN)
Bicara Therapeutics (BCAX)
Nurix Therapeutics (NRIX)
Apogee Therapeutics (APGE)
Ascendis Pharma A/S Sponsored Adr (ASND)
Immunocore Holdings Ads (IMCR)
Taysha Gene Therapies Com Shs (TSHA)
Dyne Therapeutics (DYN)
Sanofi SA Sponsored Adr (SNY)

View all positions for Vestal Point Capital

Top funds holding Galecto

Fairmount Funds Management
VR Adviser
RA Capital Management
Henderson Group
Viking Global Investors
Remedium Capital Partners
Commodore Capital
Cormorant Asset Management
Balyasny Asset Management
AH Capital Management
Perceptive Advisors
Point72 Asset Management
Braidwell
Vestal Point Capital
Blackstone Group

View all funds holding Galecto